PrivatePulse·Companies·Ramp vs Brex

Ramp vs Brex: employee equity compared

Secondary market prices, valuation trajectory, equity structure, and liquidity outlook for employees choosing between Ramp and Brex.

Secondary market data updated monthly · Sources: Hiive, Forge
↑ Higher secondary premium

Ramp

Fintech · New York, NY · Founded 2019

Corporate cards and spend-intelligence platform.

Last primary round$8.1B · Series D+ (2024-01)
Secondary market$8.8B (+9% vs primary)
Annual revenue$0.4B ARR · +70% YoY (fast)
Headcount~1,200
Equity typeISO/NSO
Strike price range$22–$40 (depends on cohort)
Illiquidity discount~18%
Last round leadKhosla Ventures
Liquidity outlook

IPO possible 2027–2029 once ARR milestones are hit. Secondary indication near primary round valuation. Strategic M&A also plausible in consolidating sector.

Key equity angle

Recurring revenue model; ISO/NSO options; IPO likely once profitability demonstrated

Brex

Fintech · San Francisco, CA · Founded 2017

Corporate cards and spend-management platform for startups and growth companies.

Last primary round$12.3B · Series D extension (2022-01)
Secondary market$11.2B (-9% vs primary)
Annual revenue$0.4B ARR · +30% YoY (solid)
Headcount~1,200
Equity typeISO/NSO
Strike price range$30–$52 (depends on cohort)
Illiquidity discount~18%
Last round leadTiger Global / Greenoaks
Liquidity outlook

IPO plausible 2027–2029 if growth trajectory holds. Liquidity may come via tender offer or strategic acquisition before listing.

Key equity angle

Recurring revenue model; ISO/NSO options; IPO likely once profitability demonstrated

Key differences for employees

Equity structure

Ramp grants ISO/NSO with strike prices ranging from $22–$40 depending on your grant year. Brex grants ISO/NSO with strike prices from $30–$52.

Secondary market premium

The secondary market is pricing Ramp at a +9% premium over its last primary round ($8.1B$8.8B). Brex trades at +-9% over its last round ($12.3B$11.2B). A higher secondary premium signals stronger investor demand and potentially better near-term liquidity for employees looking to sell.

Revenue and growth

Ramp runs at $0.4B ARR, growing +70% YoY (fast). Brex runs at $0.4B ARR, growing +30% YoY (solid). Revenue growth rate matters for equity because it drives the peer-multiple valuation — the method most correlated with exit multiples.

Liquidity timeline

Ramp: IPO possible 2027–2029 once ARR milestones are hit. Secondary indication near primary round valuation. Strategic M&A also plausible in consolidating sector.

Brex: IPO plausible 2027–2029 if growth trajectory holds. Liquidity may come via tender offer or strategic acquisition before listing.

Calculate your specific grant

Enter your actual shares, equity type, and strike price. PrivatePulse calculates your personal equity value at both companies using 4 independent methods.

Frequently asked questions

Is Ramp or Brex a better company to work at for equity?
There's no universal answer — it depends on your risk profile, time horizon, and specific grant terms. Ramp at $8.1B and Brex at $12.3B offer very different risk/reward profiles. Use the calculator above to model your exact grant at each company.
How do I know if my Ramp or Brex equity is fairly priced?
Compare your grant's implied per-share value against the secondary market price. If investors are paying a premium on Hiive or Forge over the last primary round, that's a signal of strong demand. PrivatePulse shows you the gap between your 409A and what the secondary market says.
Can I sell my Ramp or Brex shares on the secondary market?
Secondary market transactions (Hiive, Forge, Caplight) require accredited investor status and your company's consent — most private companies have right-of-first-refusal (ROFR) provisions. Tender offers, when available, are typically the most accessible path to partial liquidity for employees.

More equity comparisons